Blood banking issues pertaining to neonatal red blood cell transfusions

Transfusion Science

Volumn 21, Issue 1, 1999, Pages 7-19

  Strauss, Ronald G ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ANTICOAGULATION; BLOOD BANK; BLOOD CLOTTING; BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; HUMAN; HUMAN CELL; NEWBORN; PATHOPHYSIOLOGY; PREMATURITY; REVIEW;

EID: 0347662212     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(99)00063-6     Document Type: Article

References (52)

1. Strauss RG. Current issues in neonatal transfusions. Vox Sang 1986;51:1.
2. Dallman PR. Anemia of prematurity. Annu Rev Med 1981;32:143.
3. Stockman JA. Anemia of prematurity: Current concepts in the issue of when to transfuse. Pediatr Clin North Am 1986;33:111.
4. Brown MS, Phibbs RH, Garcia JF, et al. Postnatal changes in erythropoietin levels in untransfused premature infants. J Pediatr 1983;103:612.
5. Stockman JA III, Graeber JE, Clark DA, et al. Anemia of prematurity: Determinants of the erythropoietin response. J Pediatr 1984;105:786.
6. Shannon KM, Naylor GS, Tordildson JC, et al. Circulating erythroid progenitors in the anemia of prematurity. N Engl J Med 1987;317:728.
7. Rhondeau SM, Christensen RD, Ross MP, et al. Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with "anemia of prematurity." J Pediatr 1988;112:935.
8. Holbrook ST, Christensen RD, Rothstein G. Erythroid colonies derived from fetal blood display different growth patterns from those derived from adult marrow. Pediatr Res 1988;24:605.
9. Zanjani ED, Ascensao JL, McGlave PB, et al. Studies in the liver to kidney switch of erythropoietin production. J Clin Invest 1981;67:1183.
10. Dame C, Fahnenstich H, Freitag P, et al. Erythropoietin mRNA expression in human fetal and neonatal tissue. Blood 1998;92:3218.
11. Widness JA, Susa JB, Garcia JF, et al. Increased erythropoiesis and elevated erythropoietin in infants born to diabetic mothers and in hyperinsulinemic rhesus fetuses. J Clin Invest 1981;67:637.
12. Snijders RJM, Abbas A, Melby O, et al. Fetal plasma erythropoietin concentration in severe growth retardation. Am J Obstet Gynecol 1993;168:615.
13. Ohls RK, Yan LI, Trautman MS, et al. Erythropoietin production by macrophages from preterm infants: implications regarding the cause of the anemia in prematurity. Pediatr Res 1994;35:169.
14. Widness JA, Veng-Pedersen P, Peters C, et al. Erythropoietin pharmacokinetics in premature infants: developmental, nonlinearity, and treatment effects. J Appl Physiol 1996;80:140.
15. Ruth V, Widness JA, Raivio KO. Postnatal changes in serum Ep in relation to hypoxia before and after birth. J Pediatr 1990;116:950.
16. George JW, Bracco C, Shannon K, et al. Response of rhesus monkeys to recombinant human erythropoietin: Comparison of adults and infants (Abstract). Pediatr Res 1989;25:269A.
17. Sacher RA, Luban NLC, Strauss RG. Current practice and guidelines for the transfusion of cellular blood components in the newborn. Transfus Med Rev 1989;3:39.
18. Widness JA, Seward VJ, Kromer IJ, et al. Changing patterns of red blood cell transfusion in very low birth weight infants. J Pediatr 1996;129:680.
19. Strauss RG. Red blood cell transfusion practices in the neonate. Clin Perinatol 1995;22:641.
20. Ringer SA, Richardson DK, Sacher RA, et al. Variations in transfusion practice in neonatal intensive care. Pediatrics 1998;101:194.
21. Blanchette VS, Hume HA, Levy GJ, et al. Guidelines for auditing pediatric blood transfusion practices. Am J Dis Child 1991;145:787.
22. Kattwinkel J. Neonatal apnea: pathogenesis and therapy. J Pediatr 1977;90:342.
23. Joshi A, Gerhardt T, Shandloff P, et al. Blood transfusion effect on the respiratory pattern of preterm infants. Pediatrics 1987;80:79.
24. Keyes WG, Donohue PK, Spivak JL, et al. Assessing the need for transfusion of premature infants and role of hematocrit, clinical signs, and erythropoietin level. Pediatrics 1989;84:412.
25. Poets CF, Pauls U, Bohnhorst B. Effect of blood transfusion on apnoea, bradycardia and hypoxasmia in preterm infants. Eur J Pediatr 1997;156:311.
26. Stockman JA, Clark DA. Weight gain: a response to transfusion in selected preterm infants. Am J Dis Child 1984;138:828.
27. Blank JP, Sheagren TG, Cajaria J, et al. The role of RBC transfusion in the premature infant. Am J Dis Child 1984;138:831.
28. Lachance C, Chessex P, Fouron JC, et al. Myocardial, erythropoietic, and metabolic adaptations to anemia of prematurity. J Pediatr 1994;125:278.
29. Phillips HM, Holland BM, Abdel-Moiz A, et al. Determination of red cell mass in assessment and management of anaemia in babies needing blood transfusion. Lancet 1986;1:882.
30. Jones JG, Holland BM, Veale KEA, et al. "Available oxygen," a realistic expression of the ability of the blood to supply oxygen to tissues. Scand J Haematol 1979;22:77.
31. Alverson DC, Isken VH, Cohen RS. Effect of booster blood transfusions on oxygen utilization in infants with bronchopulmonary dysplasia. J Pediatr 1988;113:722.
32. Hudson IR, Cavill IA, Cooke AD, et al. Biotin labeling of red cells in the measurement of red cell volume in preterm infants. Pediatr Res 1990;28:199.
33. Hudson I, Cooke A, Holland B, et al. Red cell volume and cardiac output in anaemic preterm infants. Arch Dis Child 1990;65:672.
34. Mock DM, Lankford GL, Widness JA, et al. Measurement of circulating red blood cell volume by a non-radioactive, biotin method: Validation against 51Cr labeled red cells. Transfusion 1999;39:149.
35. Luban NLC, Strauss RG, Hume HA. Commentary on the safety of red blood cells preserved in extended storage media for neonatal transfusions. Transfusion 1990;31:229.
36. Liu EA, Mannio FL, Lane TA. Prospective, randomized trial of the safety and efficacy of a limited donor exposure transfusion program for premature neonates. J Pediatr 1994;125:92.
37. Lee DA, Slagel TA, Jackson TM, Evans CS. Reducing blood donor exposures in low birth weight infants by the use of older, unwashed packed red blood cells. J Pediatr 1995;125:92.
38. Wood A, Wilson N, Skacel P, et al. Reducing donor exposure in preterm infants requiring blood transfusions. Arch Dis Child 1995;72:F29.
39. Asch J, Wedgewood JF. Optimizing the approach to anemia in the preterm infant: is there a role for erythropoietin therapy?. J Perinatol 1997;17:276.
40. Strauss RG, Burmeister LF, Johnson K, et al. AS-1 red blood cells for neonatal transfusions: a randomized trial assessing donor exposure and safety. Transfusions 1996;36:873.
41. Wood L, Beutler E. Temperature dependence of sodium-potassium activated erythrocyte adenosine triphosphatase. J Lab Clin Med 1967;70:287.
42. Valeri CR, Hirsch NM. Restoration in vivo of erythrocyte adenosine triphosphate 2,3-diphosphoglycerate potassium ion, and sodium ion concentrations following the transfusion of acid-citrate-dextrose-stored human red blood cells. J Lab Clin Med 1969;73:722.
43. Strauss RG, Villhauer PJ, Cordle DG. A method to collect store and issue multiple aliquots of packed red blood cells for neonatal transfusions. Vox Sang 1995;68:77.
44. Clay M, Kline W, McCullough J. The frequency of granulocyte-specific antibodies in postpartum sera and a family study of the GB antigen. Transfusion 1984;24:252.
45. Hart D, Dunetz C, Nardi M, et al. An epidemic of maternal thrombocytopenia associated with elevated antiplatelet antibody. Am J Obstet Gynecol 1986;154:878.
46. Samuels P, Main EK, Tomaski, et al. Abnormalities in platelet antiglobulin tests in preeclamptic mothers and their neonates. Am J Obstet Gynecol 1987;157:109.
47. Strauss RG. Recombinant erythropoietin for the anemia of prematurity: still a promise, not a panacea. J Pediatr 1997;131:653.
48. Strauss RG. Erythropoietin in the pathogenesis and treatment of neonatal anemia. Transfusion 1995;35:68.
49. Shannon KM, Keith JF, Mentzer WC, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very-low-birth-weight preterm infants. Pediatrics 1995;95:1.
50. Ohls RK, Veerman MW, Christensen RD. Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution. J Pediatr 1996;128:518.
51. Ohls RK, Harcum J, Schibler KR, et al. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study. J Pediatr 1997;131:661.
52. Doyle JJ. The role of erythropoietin in the anemia of prematurity. Semin Perinatol 1997;21:20.